Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2007.028 | A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group, 8-Week Comparative Efficacy and Safety Study of Esomeprazole 20 mg qd Versus Ranitidine 150 mg bid in Patients with An NSAID-Associated Gastric Ulcer When Daily NSAID is Continued | Prof. Chan KL Francis |
| 2004.116 | H. Pylori-negative Idiopathic Bleeding Ulcer: An Emerging Disease in the Post-H. Pylori era. | CHAN KL Francis |
| 2003.108 | Preventing NSAID-Associated Ulcer Bleeding for High-Risk Patients: From Cyclooxygenase-2 to Therapeutics (Study A. Effect of Inhibition of COX-2 on Prostaglandia Synthesis in Previously Damaged Gastric Mucosal Barrier | CHAN KL Francis |
| 2002.191 | Study of the Natural History of Non-NSAID, Non-Hp Bleeding Peptic Ulcers (NNH Study) | CHAN KL Francis |
| 2009.014 | Molecular basis of viral RNA polymerase complex as a restriction to host adaptation of influenza viruses | CHAN KS Paul |
| 2005.233 | Evaluation on Newer Serological Markers for Early Detection of Nasopharyngeal Carcinoma | CHAN KS Paul |
| 2006.146 | Investigation of the Possible Detection of Methylated RASSF1A Sequence in the Plasma of Healthy Control Subjects and its Quantitative Relationship with Age | CHAN Kwan Chee Allen |
| 2004.131 | Serial Analysis of the Molecular Size of Plasma Epstein-Barr virus and Genomic DNA during Radiotherapy in Nasopharyngeal Carcinoma Patients | CHAN Kwan Chee Allen |
| 2005.013 | Plasma EBV DNA Analysis in Patients with Renal Disease | CHAN Kwan Chee Allen |
| 2004.194 | Blood Markers in Acute Appendicitis: Development of a Rapid Test for the Early Diagnosis of Acute Appendicitis | CHAN Kwan Chee Allen |
| 2005.105 | Investigation of the Integrity of Circulating Cell-Free RNA in the Plasma of Pregnant Women | CHAN Kwan Chee Allen |
| 2004.061 | Role of ERRs in the Development of Prostrate Cancer | CHAN L Franky |
| 2006.347 | An Open-Label, Multicenter, Randomized Study of Combination Therapy with Oral Telbivudine Plus Adefovir Dipivoxil Versus Adefovir Dipivoxil Alone in HBeAg-Positive Patients with Chronic Hepatitis B Who are Lamivudine Resistant | Prof. Chan L.Y. Henry |
| 2007.322 | A Randomized, Double-Blind Study Evaluating Tenofovir Disoproxil Fumarate (DF) Monotherapy versus the Combination of Emtricitabine and Tennofovir DF for the Treatment of Chronic Hepatitis B | Prof. Chan L.Y. Henry |
| 2004.107 | Reducing Blood Exposures and Sharps-Related Injuries in Operating Theatre | CHAN Lai Sze Connie (No email contact) |
| 2006.131 | Epigenetic Inactivation of Wnt Inhibitoary Factor 1 (WIF-1) in Hepatocellular Carcinoma | CHAN Lam |
| 2007.077 | Noise Level Measurement at Public Hospitals in Hong Kong | CHAN Lam Lam Anne |
| 2010.205 | Prospective randomized double-blind placebo controlled trial to assess the role of lamivudine in patients with hepatitis B related-hepatocellular carcinoma not suitable for oncologic therapy due to poor liver function | Prof. Chan Lam Stephen |
| 2010.356 | A Multicenter, Randomized, Double-Blind, Phase 3 Study of Ramucirumab (IMC-1121B) Drug Product and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma Following First-Line Therapy With Sorafenib | Dr. Chan Lam Stephen |
| 2011.426 | The use of serum interleukin-6 and interleukin-10 in prognostication of advanced hepatocellular carcinoma | CHAN Lam Stephen |
| 2004.426 | Interface of Diagnostic Method Between Chinese and Western Medicine in Chronic Hepatitis B | CHAN Lik Yuen Henry |
| 2009.487 | Evaluation of 3' deleted HBx mutant as a serum marker to predict hepatocellular carcinoma in chronic hepatitus B | CHAN Lik Yuen Henry |
| 2009.438 | Association of serum hepatitis B surface antigen level with the risk of hepatocellular carcinoma | CHAN Lik Yuen Henry |
| 2004.336 | Role of Hepatitis B Virus Covalently Closed Circular DNA in Determination of Treatment Outcome | CHAN Lik Yuen Henry |
| 2010.144 | The impact of drug resistance testing in the management of patients with chronic hepatitis B on antiviral therapy - A retrospective study and survey | CHAN Lik Yuen Henry |
| 2009.318 | Health Related Quality of Life in Patients with Chronic Hepatitis C in Hong Kong | CHAN Lik Yuen Henry |
| 2012.216 | Risk of advanced colorectal neoplasm in patients with non-alcoholic fatty liver disease | CHAN Lik Yuen Henry |
| 2010.071 | Presictive value of week 24 response for long-term outcomes of entecavir therapy in patients with chronic hepatitis B | CHAN Lik Yuen Henry |
| 2009.242 | Viral Genomic Determinatns of Liver Fibrosis in Chronic Hepatitis B | CHAN Lik Yuen Henry |
| 2004.344 | Proteomic Profiling of Liver Fibrosis in Chronic Hepatitis B | CHAN Lik Yuen Henry |
| 2013.264 | A multi-centre 3-year follow-up study to assess the viral activity in patients who failed to achieve sustained virologic response in Novartis-sponsored Alisporivir-studies for chronic Hepatitis C patients | Prof. Chan Lik Yuen Henry |
| 2006.297 | Surveillance for Early Liver Cirrhosis in Chronic Hepatitis B Patients in Hong Kong Using Transient Elastography | CHAN Lik Yuen Henry |
| 2002.338 | A Study on the Viral Kinetics of Different Regimes of Pegylated Interferon and Lamivudine Combination Theerpy in HBeAg Positive Chronic Hepatitis B (Revised : cre-2002.203-t) | Prof. Chan Lik Yuen Henry |
| 2007.353 | Use of Serum Hepatitis B Surfact Antigen Quantitation to Monitor Treatment Response in Chronic Hepatitis B | CHAN Lik Yuen Henry |
| 2006.427 | Effect of Alanine Aminotransamine Levels on the Liver Stiffness Measurement by Transient Elastography (Fibroscan) in Viral Hepatitis | CHAN Lik Yuen Henry |
| 2005.458 | Hepatitis B Virus DNA and Liver-related Complications | CHAN Lik Yuen Henry |
| 2005.279 | An Open Label Trial of Telbivudine (LdT) in Adults with Chronic Hepatitis B Previously Treated in Indenix-Sponsored Telbivudine Studies | Prof. Chan Lik Yuen Henry |
| 2007.203 | Virological Monitoring of Anti-Viral Treatment in Chronic Hepatitis B | CHAN lik Yuen Henry |
| 2007.352 | The Role of Hepatitis B Virus Encoded MicroRNAs | CHAN Lik Yuen Henry |
| 2011.284 | A randomized, double-blind, placebo-controlled trial of the efficacy and safety of DEB025/Alisporivir in combination with peg-IFN | Prof. Chan Lik Yuen Henry |
| 2007.206 | A Comparative Study of Entecavir vs Adefovir plus Lamivudine vs Combination Entecavir plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Subjects: The DEFINE Study | Prof. Chan Lik Yuen Henry |
| 2005.028 | A Randomized, Blinded, Phase IIb Trial of Telbivudine (LdT) versus the Combination of Telbivudine and Valtorcitabine (Val-LdC) in Patients with Chronic Hepatitis B | Prof. Chan Lik Yuen Henry |
| 2005.048 | Treatment with Peginterferon Alfa-2a (40 KD) (PEGASYS_) of Chronic Hepatitis B Patients, Who Have Failed Anti-Viral Treatment | Prof. Chan Lik Yuen Henry |
| 2007.368 | Public Awareness of Chronic Hepatits B | CHAN Lik Yuen Henry |
| 2007.369 | Hong Kong Hepatitis B Women Patients' Concerns Survey | CHAN Lik Yuen Henry |
| 2005.428 | Intrahepatic Assessment of Hepatitis B Virus in Hepatocellular Carcinoma | CHAN Lik Yuen Henry |
| 2006.039 | Long-Term Follow-up of Patients Who Completed Serono Protocol 23744 for the Treatment of Chronic Hepatitis C Using Interferon-Beta-1a | CHAN Lik Yuen Henry |
| 2006.330 | Effect of Short-Term Corticosteroid on the Viral Kinetics of Hepatitis B Virus in Patients with Exacerbation of Chronic Obstructive Pulmonary Disease | CHAN Lik Yuen Henry |
| 2003.148 | A Multinational Phase 2 Study of LY582563 in the Treatment of Patients with Chronic Hepatitis B Viral Infection | Prof. Chan Lik Yuen Henry |
| 2004.332 | Double-blinded, Randomized Trial of Thymosin-alfa-1 and Peginterferon alfa-2a (40 KD) (PEGASYS_) Combination Therapy versus Peginterferon Alfa-2a (40 KD) (PEGASYS_) Monotherapy in the Treatment of Chronic Hepatitis B | Prof. Chan Lik Yuen Henry |
Page 4 of 254.